236 related articles for article (PubMed ID: 26320193)
1. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
[TBL] [Abstract][Full Text] [Related]
2. The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.
Ungewiss C; Rizvi ZH; Roybal JD; Peng DH; Gold KA; Shin DH; Creighton CJ; Gibbons DL
Sci Rep; 2016 Jan; 6():18652. PubMed ID: 26728244
[TBL] [Abstract][Full Text] [Related]
3. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway.
Hsu YL; Wu CY; Hung JY; Lin YS; Huang MS; Kuo PL
Carcinogenesis; 2013 Jun; 34(6):1370-81. PubMed ID: 23389289
[TBL] [Abstract][Full Text] [Related]
5. S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration.
Du M; Wang G; Ismail TM; Gross S; Fernig DG; Barraclough R; Rudland PS
J Biol Chem; 2012 May; 287(19):15330-44. PubMed ID: 22399300
[TBL] [Abstract][Full Text] [Related]
6. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-1 promotes colorectal cancer invasion and metastasis through crosstalk with S100P.
Lin F; Zhang P; Zuo Z; Wang F; Bi R; Shang W; Wu A; Ye J; Li S; Sun X; Wu J; Jiang L
Cancer Lett; 2017 Aug; 401():1-10. PubMed ID: 28483515
[TBL] [Abstract][Full Text] [Related]
8. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
9. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
10. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
11. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
[TBL] [Abstract][Full Text] [Related]
12. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
13. Functional evidence implicating S100P in prostate cancer progression.
Basu GD; Azorsa DO; Kiefer JA; Rojas AM; Tuzmen S; Barrett MT; Trent JM; Kallioniemi O; Mousses S
Int J Cancer; 2008 Jul; 123(2):330-339. PubMed ID: 18452169
[TBL] [Abstract][Full Text] [Related]
14. Molecular regulation of S100P in human lung adenocarcinomas.
Rehbein G; Simm A; Hofmann HS; Silber RE; Bartling B
Int J Mol Med; 2008 Jul; 22(1):69-77. PubMed ID: 18575778
[TBL] [Abstract][Full Text] [Related]
15. The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells.
Su Y; Guan XQ; Liu FQ; Wang YL
Int J Mol Med; 2014 Sep; 34(3):842-8. PubMed ID: 24970008
[TBL] [Abstract][Full Text] [Related]
16. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
17. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
[TBL] [Abstract][Full Text] [Related]
18. Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis.
Jiang L; Lai YK; Zhang J; Wang H; Lin MC; He ML; Kung HF
Mol Med; 2011; 17(7-8):709-16. PubMed ID: 21327297
[TBL] [Abstract][Full Text] [Related]
19. shRNA‑mediated silencing of TARBP2 inhibits NCI‑H1299 non‑small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway.
Shi Y; Zuo D; Wang X; Han M; Wu Y
Mol Med Rep; 2016 Oct; 14(4):3725-30. PubMed ID: 27599909
[TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
